Read the Latest News

Metal Implants and Dental Amalgam: The FDA Announces Public Meeting and Paper

The U.S. Food and Drug Administration (FDA) announced a paper on metal-containing implants and a panel meeting as part of ongoing efforts to evaluate materials in medical devices to address potential safety questions.

Drug Induced Bruxism

The authors of this article state that orofacial movement disorders (bruxism) are treated typically by dental professionals and not by those specialists (neurologists) researching and treating the other movement disorders (Parkinson's disease, Huntington's disease, tremors, etc.). Again, this is more evidence of the complexity of TMD and the need for multidisciplinary research and treatment in TMD.

Cervical Muscle Tenderness in Temporomandibular Disorders and Its Associations with Diagnosis, Disease-Related Outcomes, and Comorbid Pain Conditions

To analyze cervical tenderness scores (CTS) in patients with various temporomandibular disorders (TMD) and in controls and to examine associations of CTS with demographic and clinical parameters.

You, Your Esophagus and TMD

The esophagus is a roughly ten-inch hollow tube that descends from your throat through the diaphragm into the stomach. Normally, it is a one-way street transporting food you swallow to the stomach for digestion. But in GERD— Gastroesophageal Reflux Disease— the flow can reverse so that stomach contents (including gastric acids) are regurgitated upwards to cause a burning sensation (heartburn), nausea, pain and other distressing symptoms.

It's Time to Be Part of the Solution

The National Academy of Medicine (NAM) Study on Temporomandibular Disorders (TMD) is well underway. We strongly encourage everyone affected by TMD to write to the NAM committee letting them know what it is like to live with TMD and your experiences with getting care.

Survey Profiles TMD Patients

  • Jan 14, 2015

TMJA Survey Results

  • The individuals affected by Temporomandibluar Joint Disorders (TMD) were on average 41 years of age and predominantly female (90%).
  • Nearly 60% of both men and women reported recent pain of moderate-to-severe intensity with a quarter of them indicating interference or termination of work-related activities.
  • In the case-control comparison, a higher frequency of headaches, allergies, depression, fatigue, degenerative arthritis, fibromyalgia, autoimmune disorders, sleep apnea, and gastrointestinal complaints were prevalent among those affected with TMD. Many of the associated comorbid conditions were over 6 times more likely to occur after TMD was diagnosed.
  • Among a wide array of treatments used (46 listed), the most effective relief for most affected individuals (91%) was the use of thermal therapies—hot/cold packs to the jaw area or hot baths.
  • Nearly 40% of individuals affected with TMD reported one or more surgical procedures and nearly all were treated with one or many different medications. Results of these treatments were generally equivocal.

How the TMJA's Survey Came About...

Since The TMJ Association began in 1986, we have been privy to TMJ experiences. We’ve heard from patients and family members here and abroad via phone, fax, mail, and email--all sharing stories of pain and problems with speaking, chewing, swallowing, and even kissing loved ones.
 
There were grim stories about trying to find an understanding practitioner, the cost of care, the lack of insurance and even worse—accounts of failed treatments.  You’ve shared ideas for coping and alleviating pain. Other times, you described additional health problems that seemed to develop along with the Temporomandibular Disorder (TMD).

Because of your input, the TMJA has been able to  gather a wealth of information about TMD in all their complexity. Not surprisingly, it occurred to us that there should be a way to organize this information in such a way as to provide patients, providers, and scientists with a fuller understanding of these conditions - who experiences them, and the treatments being recommended to TMJ patients and whether these treatments help them.

Thus was born the idea of a major survey to be designed, conducted, and analyzed by outside experts whose participation would lend credibility to the survey. With headquarters in Milwaukee and access to the Medical College of Wisconsin (MCW), the TMJA contacted four MCW professors who rose to the challenge: Raymond Hoffman, PhD, is a biostatistician and Associate Director of Quantitative Health Sciences in MCW’s Department of Pediatrics, Jane Morley Kotchen, MD, MPH, Director and Professor in the Master in Public Health Program of the Institute for Health and Society, Theodore Kotchen, MD, Professor of Medicine and Associate dean for Clinical Research, in the Department of Medicine Division of Endocrinology, Metabolism, and Clinical Nutrition, and Allen W. Cowley, Jr., Ph.D., Director of the Cardiovascular Center & Chairman of the Department of Physiology.

Together, the team, working with TMJA, drafted an extensive questionnaire demographic information (age, sex, marital status), reproductive history, family history of TMD, age at which the symptoms first occurred and age of diagnosis, respondent’s concepts about causes of symptoms, procedures related to TMD, and selected medications. We also wanted to identify the spectrum of clinical manifestations and therapeutic strategies associated with TMD from the perspective of the affected individuals, and to compare the prevalence of comorbid conditions and symptoms in affected individuals to a comparable group of unaffected individuals similar in age and sex.

Review and approval of the survey and protocol by MCW’s Institutional Review Board (mandated to protect the rights of human subjects) took several months, but in due course the invitation to participate was electronically mailed to 10,000 TMJA registrants. A little over one-third of the registrants actually received the invitation and 43 percent responded, for a total of 1,511 respondents, 1,358 women and 153 men. Our thanks go to the survey participants and scientists who made this possible. Results of the survey were published in the Clinical Journal of Pain, Volume 27, Number 3, March/April 2011, pp. 268-274.

Dr. Jane Kotchen, a co-author of the survey presented the findings at the TMJA's Fourth Scientific Meeting. Click here to view the PowerPoint presentation.

TMJ Disorders

Comments:

Login or Register to add Comment